<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03704623</url>
  </required_header>
  <id_info>
    <org_study_id>Parecoxib vs Paracetamol</org_study_id>
    <nct_id>NCT03704623</nct_id>
  </id_info>
  <brief_title>Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic</brief_title>
  <official_title>Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic Due to Ureteric Calculi: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amiri Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted to compare the efficacy and safety of Parecoxib versus
      Paracetamol for treatment of acute renal colic due to ureteric stones.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible patients will be randomized to one of the two treatment groups. Group 1 patients
      will receive IV 1 g of Paracetamol while group 2 patients will receive 40 mg of Parecoxib IV.

      The Visual Analogue Scale (VAS) will be calculated on presentation and at 30 minutes after
      analgesia administration. Patients who do not respond to an initial dose of the analgesia
      will receive rescue analgesia in the form of Morphine, 01.mg/kg, IV.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Eligible patients will be randomized to one of the two treatment groups.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>The emergency department (ED) nurse will do randomization by drawing one of the sealed closed envelopes that contain the analgesic to be administered.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The need for rescue analgesia (Morphine)</measure>
    <time_frame>30 minutes</time_frame>
    <description>Patient who had persistent pain or less than 50% reduction of pain score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of adverse effects due to medication used</measure>
    <time_frame>24 hours</time_frame>
    <description>Assessment of adverse effects of the drug used</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Renal Colic</condition>
  <condition>Ureteric Stone</condition>
  <arm_group>
    <arm_group_label>Paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive IV 1 g of Paracetamol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parecoxib</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive 40 mg of Parecoxib IV</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>Paracetamol 1g IV</description>
    <arm_group_label>Paracetamol</arm_group_label>
    <other_name>Perfalgan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Parecoxib</intervention_name>
    <description>Parecoxib 40 mg IV</description>
    <arm_group_label>Parecoxib</arm_group_label>
    <other_name>Dynastat</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical signs and symptoms consistent with acute renal colic

          -  Pain score more than 5

        Exclusion Criteria:

          -  Hypersensitivity to either Paracetamol or Parecoxib.

          -  Previous history of urolithiasis within the last 6 months.

          -  History of active GI bleeding or peptic ulcer.

          -  Pregnant or breastfeeding females.

          -  Patients with hepatic impairment (Child-Pugh score &gt;10 or Serum Albumin &lt;25g/L).

          -  Patients with chronic kidney disease (CKD) Stage 4 or 5 (eGFR &lt;30mls/min).

          -  History of myocardial infarction, coronary artery by-pass grafting, peripheral
             vascular disease.

          -  History of cerebrovascular disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdullatif AL-Terki, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Amiri Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed R Elnahas, MD</last_name>
    <phone>0096555754386</phone>
    <phone_ext>55754386</phone_ext>
    <email>ar_el_nahas@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jaffar M Hussain, MD</last_name>
    <phone>0096595571992</phone>
    <phone_ext>0096595571992</phone_ext>
    <email>jayphar21@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Al-Amiri Hospital</name>
      <address>
        <city>Kuwait</city>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed R EL-Nahas, MD</last_name>
      <phone>0096555754386</phone>
      <phone_ext>0096555754386</phone_ext>
      <email>ar_el_nahas@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Jaffar M Hussain, MD</last_name>
      <phone>0096595571992</phone>
      <email>jayphar21@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Kuwait</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 10, 2018</study_first_submitted>
  <study_first_submitted_qc>October 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2018</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Ahmed R. EL-Nahas</investigator_full_name>
    <investigator_title>Professor of Urology</investigator_title>
  </responsible_party>
  <keyword>Acute renal colic</keyword>
  <keyword>Ureteric stone</keyword>
  <keyword>Selective COX2 inhibitor</keyword>
  <keyword>Parecoxib</keyword>
  <keyword>Paracetamol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ureteral Calculi</mesh_term>
    <mesh_term>Ureterolithiasis</mesh_term>
    <mesh_term>Colic</mesh_term>
    <mesh_term>Renal Colic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Parecoxib</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

